c-Myc proteolysis by the ubiquitin-proteasome pathway: Stabilization of c-Myc in Burkitt's lymphoma cells

Molecular and Cellular Biology

Volumn 20, Issue 7, 2000, Pages 2423-2435

  Gregory, Mark A ^a   Hann, Stephen R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEASOME; UBIQUITIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BURKITT LYMPHOMA; CELL STRAIN 3T3; COLON CARCINOMA; GENE MUTATION; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BURKITT LYMPHOMA; COS CELLS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; HUMANS; MICE; MITOSIS; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; MUTATION; NEOPLASM PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-MYC; SEQUENCE DELETION; TRANSFECTION; TUMOR CELLS, CULTURED; UBIQUITINS;

ANIMALIA;

EID: 0034059667     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.7.2423-2435.2000     Document Type: Article

References (76)

1. Albert, T., B. Urlbauer, F. Kohlhuber, B. Hammerson, and D. Eick. 1994. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. Oncogene 9:759-763.
2. Asker, C., M. Steinitz, K. Andersson, J. Sumegi, G. Klein, and S. Ingvarsson. 1989. Nucleotide sequence of the rat Bmyc gene. Oncogene 4:1523-1527.
3. Asker, C. E., K. P. Magnusson, S. P. Piccoli, K. Andersson, G. Klein, M. D. Cole, and K. G. Wiman. 1995. Mouse and rat B-myc share amino acid sequence homology with the c-myc transcriptional activator domain and contain a B-myc specific carboxy terminal region. Oncogene 11:1963-1969.
4. Axelson, H., M. Henriksson, Y. Wang, K. P. Magnusson, and G. Klein. 1995. The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines hut not in mouse plasmacytomas and rat immunocytes. Eur. J. Cancer 31A:2099-2104.
5. Bader, J. P., F. A. Hausman, and D. A. Ray. 1986. Intranuclear degradation of the transformation-inducing protein encoded by avian MC29 virus. J. Biol. Chem. 261:8303-8308.
6. Barrett, A. J., A. A. Kembhavi, M. A. Brown, H. Kirschke, C. G. Knight, M. Tamai, and K. Hanada. 1982. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H, and L. Biochem. J. 201:189-198.
7. Bhatia, K., K. Huppi, G. Spangler, D. Siwarski, R. Iyer, and I. Magrath. 1993. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat. Genet. 5:56-61.
8. Bies, J., and L. Wolff. 1997. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway. Oncogene 14:203-212.
9. Brown, K., G. Franzoso, L. Baldi, L. Carlson, L. Mills, Y.-C. Lin, S. Gerstberger, and U. Siebenlist. 1997. The signal response of IκBα is regulated by transferable N-and C-terminal domains. Mol. Cell. Biol. 17:3021-3027.
10. Campanero, M. R., and E. K. Flemington. 1997. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94:2221-2226.
11. Ciechanover, A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79:13-21.
12. Ciechanover, A. 1998. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 17:7151-7160.
13. Claassen, G. F., and S. R. Hann. 1999. Myc-mediated transformation: the repression connection. Oncogene 18:2925-2933.
14. Clark, H. M., T. Yano, T. Otsuki, E. S. Jaffe, D. Shibata, and M. Raffeld. 1994. Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas. Cancer Res. 54:3383-3386.
15. Conn, S. L., H. Salwen, M. W. Quasney, N. Ikegaki, J. M. Cowan, C. V. Herst, R. H. Kennett, S. T. Rosen, J. A. DiGiuseppe, and G. M. Brodeur. 1990. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification. Oncogene 5:1821-1827.
16. Cole, M. D., and S. B. McMahon. 1999. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18:2916-2924.
17. Eilers, M., S. Schirm, and J. M. Bishop. 1991. The c-Myc protein activates transcription of the alpha prothymosin gene. EMBO J. 10:133-141.
18. Elledge, S. J., and J. W. Harper. 1998. The role of protein stability in the cell cycle and cancer. Biochim. Biophys. Acta 1377:M61-M70.
19. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
20. Facchini, L. M., and L. Z. Penn. 1998. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12: 633-651.
21. Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specitic amino-terminal threonine modification by lactacystin. Science 258:726-731.
22. Flinn, E. M., C. Magnus, C. Busch, and A. P. H. Wright. 1998. myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol. Cell. Biol. 18:5961-5969.
23. Grandori, C., and R. Eisenman. 1997. Myc target genes. Trends Biochem. Sci. 22:177-181.
24. Gross-Mesilaty, S., E. Reinstein, B. Bercovich, K. E. Tobias, A. L. Schwartz, C. Kahana, and A. Ciechanover. 1998. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc. Natl. Acad. Sci. USA 95:8058-8063.
25. Hann, S. R., H. D. Abrams, L. R. Rohrschneider, and R. N. Eisenman. 1983. Proteins encoded by v-Myc and c-Myc oncogenes: identification and localization in acute leukemia transformants and bursal lymphoma cell lines. Cell 34:789-798.
26. Hann, S. R., M. Dixit, R. C. Sears, and L. Sealy. 1994. The alternatively initiated c-Myc proteins differentially regulate transcription through a non-canonical DNA-binding site. Genes Dev. 8:2441-2452.
27. Hann, S. R., and R. N. Eisenman. 1984. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4:2486-2497.
28. Harrington, E. A., M. R. Bennett, A. Fanidi, and G. I. Evan. 1994. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13:3286-3295.
29. Hateboer, G., R. M. Kerkhoven, A. Shvarts, R. Bernards, and R. L. Beijersbergen. 1996. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev. 10:2960-2970.
30. Henriksson, M., A. Bakardjiev, G. Klein, and B. Luscher. 1993. Phosphorylation sites mapping in the N-terminal domain of c-Myc modulate its transforming potential. Oncogene 8:3199-3209.
31. Henriksson, M., and B. Luscher. 1996. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68:109-182.
32. Hoang, A. T., B. Lutterbach, B. C. Lewis, T. Yano, T.-Y. Chou, J. F. Barrett, M. Raffeld, S. R. Hann, and C. V. Dang. 1995. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol. Cell. Biol. 15:4031-4042.
33. Hofmann, F., F. Martelli, D. M. Livingston, and Z. Wang. 1996. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev. 18:2949-2959.
34. Hogarty, M. D., and G. M. Brodeur. 1999. Wild-type sequence of MYCN in neuroblastoma cell lines. Int. J. Cancer 80:630-631.
35. Isaksson, A., A. M. Musti, and D. Bohmann. 1996. Ubiquitin in signal transduction and cell transformation. Biochim. Biophys. Acta 1288:F21-F29.
36. King, M. W., J. M. Roberts, and R. N. Eisenman. 1986. Expression of the c-myc proto-oncogene during development of Xenopus laevis. Mol. Cell. Biol. 6:4499-4508.
37. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488-492.
38. Lin, R., P. Beauparlant, C. Makris, S. Meloche, and J. Hiscott. 1996. Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol. Cell. Biol. 16:1401-1409.
39. Liu, Z., R. L. Galindo, and S. A. Wasserman. 1997. A role for CKH phosphorylation of the cactus PEST domain in dorsoventral patterning of the Drosophila embryo. Genes Dev. 11:3413-3422.
40. Luscher, B., and R. N. Eisenman. 1992. Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. J. Cell Biol. 118:775-784.
41. Luscher, B., and R. N. Eisenman. 1999. c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock. Mol. Cell. Biol. 8:2504-2512.
42. Luscher, B., E. A. Kuenzel, E. G. Krebs, and R. N. Eisenman. 1989. Myc proteins are phosphorylated by casein kinase II. EMBO J. 8:1111-1119.
43. Lutterbach, B., and S. R. Hann. 1994. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol. Cell. Biol. 14:5510-5522.
44. Magrath, I. 1990. The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res. 55:133-270.
45. Maki, C. G., J. M. Huibregtse, and P. M. Howley. 1996. In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res. 56:2649-2654.
46. Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. Myc function and regulation. Annu. Rev. Biochem. 61:809-860.
47. Maleyak, M. K., A. J. Obaya, S. Adachi, and J. M. Sedivy. 1997. Phenotypes of c-Myc-defident rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8:1039-1048.
48. McElhinny, J. A., S. A. Trushin. G. D. Bren, N. Chester, and C. V. Paya. 1996. Casein kinase II phosphorylates IκBα at S-283, S-288, S-293, and T-291 and is required for its degradation. Mol. Cell. Biol. 16:899-906.
49. Pulverer, B. J., K. Fischer, K. Vousden, T. Littlewood, G. Evan, and J. R. Woodgett. 1994. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 9:59-70.
50. Rabbitts, T. H., P. H. Hamlyn, and R. Baer. 1983. Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma. Nature 306:760-765.
51. Ramsay, G., G. I. Evan, and J. M. Bishop. 1984. The protein encoded by the human proto-oncogene c-myc. Proc. Natl. Acad. Sci. USA 81:7742-7746.
52. Rechsteiner, M., and S. W. Rogers. 1996. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21:267-271.
53. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771.
54. Rogers, S., R. Wells, and M. Rechsteiner. 1986. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234: 364-368.
55. Ruf, I. K., P. W. Rhyne, H. Yang, C. M. Borza, L. M. Hutt-Fletcher, J. L. Cleveland, and J. T. Sample. 1999. Epstein-Barr virus regulates C-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Mol. Cell. Biol. 19:1651-1660.
56. 1 cyclin degradation: the PEST motif of yeast Cln2 is necessary, but not sufficient, for rapid protein turnover. Mol. Cell. Biol. 14:7953-7966.
57. Salghetti, S. E., S. Y. Kim, and W. P. Tansey. 1999. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 18:717-726.
58. Scherer, D. C., J. A. Brockman, Z. Chen, T. Maniatis, and D. W. Ballard. 1995. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92:11259-11263.
59. Schwarz, E. M., D. van Antwerp, and I. M. Verma. 1996. Constitutive phosphorylation of IκBα by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IκBα Mol. Cell. Biol. 16:3554-3559.
60. Sears, R., G. Leone, J. Degregori, and J. R. Nevins. 1999. Ras enhances Myc protein stability. Mol. Cell 3:169-179.
61. Shindo, H., E. Tani, T. Matsumuto, T. Hashimoto, and J. Furuyama. 1993. Stabilization of c-myc protein in human glioma cells. Acta Neuropathol. 86:345-352.
62. Showe, L. C., M. Ballantine, K. Nishikura, J. Erikson, H. Kaji, and C. M. Croce. 1985. Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line alpha switch region. Mol. Cell. Biol. 5:501-509.
63. Spencer, C. A., and M. Groudine. 1991. Control of c-Myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56:1-48.
64. Spotts, G. D., and S. R. Hann. 1990. Enhanced translation and increased turnover of c-myc proteins occurs during differentiation of murine erythroleukemia cells. Mol. Cell. Biol. 10:3952-3964.
65. Spotts, G. D., S. V. Patel, Q. Xiao, and S. R. Hann. 1997. Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol. Cell. Biol. 17:1459-1468.
66. Stancovski, I., H. Gonen, A. Orian, A. L. Schwartz, and A. Ciechanover. 1995. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes. Mol. Cell. Biol. 15:7106-7116.
67. Stone, J., T. de Lange, G. Ramsay, E. Jakobovits, J. M. Bishop, H. Varmus, and W. Lee. 1987. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697-1709.
68. Taub, R., C. Moulding, J. Battey, W. Murphy, T. Vasicek, G. M. Lenoir, and P. Leder. 1984. Activation and somatic mutations of the translocated c-myc gene in Burkitt lymphoma cells. Cell 36:339-348.
69. Treier, M., L. M. Staszewski, and D. Bohmann. 1994. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the 8 domain. Cell 78:787-798.
70. Tsurumi, C., N. Ishida, T. Tamura, A. Kakizuka, E. Nishida, E. Okumura, T. Kishimoto, M. Inagaki, K. Okazaki, N. Sagata, A. Ichihara, and K. Tanaka. 1995. Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases. Mol. Cell. Biol. 15:5682-5687.
71. Varshavsky, A. 1917. The ubiquitin system. Trends Biochem. Sci. 22:383-387.
72. Wang, K. K. W. 1990. Developing selective inhibitors of calpain. Trends Pharmacol. Sci. 11:139-142.
73. Waters, C. M., T. D. Littlewood, D. C. Hancock. J. P. Moore, and G. I. Evan. 1991. c-myc 1 protein expression in untransformed fibroblasts. Oncogene 6:797-805.
74. Wiman. K. C., B. Clarkson, A. C. Hayday, H. Saito, S. Tonegawa, and W. S. Hayward. 1984. Activation of a translocated c-myc gene: role of structural alterations in the upstream region. Proc. Natl. Acad. Sci. USA 81:6798-6802.
75. Xiao, Q., G. Claassen, J. Shi, S. Adachi, J. Sedivy, and S. R. Hann. 1998. Transactivation-detective c-MycS retains the ability to regulate proliferation and apoptosis. Genes Dev. 12:3803-3808.
76. Yano, T., C. A. Sander, H. M. Clark, M. V. Dolezal. E. S. Jaffe, and M. Raffeld. 1993. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. Oncogene 8:2741-2748.